High burden of variants of uncertain significance in early-onset colorectal cancer among indigenous African patients: a call for global research equity in cancer genetics
Authors:
Open Access
- 8 July 2025
- journal article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 684
Abstract
Background: Colorectal cancer (CRC) remains a significant global health challenge, with rising incidence among early-onset cases in low- and middle-income countries, including South Africa. However, comprehensive germline genetic data from indigenous African populations remain scarce. This study aimed to explore germline genetic factors contributing to early-onset CRC (eoCRC) in Indigenous African patients using whole exome sequencing (WES). Methods and results: We performed WES on blood-derived genomic DNA from 32 Indigenous African patients diagnosed with eoCRC (< 50 years), who previously tested negative on a multigene CRC panel. While preliminary but definitive, pathogenic variants were identified in only 5 patients (16%) across genes such as C6 , FAT1 , LZTR1 , PYCR1 , and UGT1A7 . A substantial proportion (47%, n = 15) carried variants of uncertain significance (VUS) with strong pathogenic potential (“leaning pathogenic”) in genes ASXL1 , CHEK2 , ERBB2 , ERCC4 , INSR , KIT , MITF , NOTCH1 , NOTCH2 , PDGFRA , RAD51B , RAD54L , RASA1 , RECQL , SUFU , VEGFA , and WT1 . Comparative analysis with public datasets and recurrent findings suggests these leaning pathogenic VUSs may represent true disease-associated variants, currently may be misclassified due to limited representation of African genomes in reference databases. Conclusions: Our findings reveal a high burden of potentially pathogenic VUSs in indigenous African patients with eoCRC, reflecting both unique genetic architecture and a critical gap in global genomic equity. These variants may contribute to future variant reclassification and improved understanding of CRC predisposition in African populations. This study underscores the urgent need for population-specific genomic research and the development of inclusive variant databases to support accurate diagnosis and personalised care.Keywords
Funding Information
- Universityof CapeTown
This publication has 50 references indexed in Scilit:
- Familial PDGFRA -mutation syndrome: somatic and gastrointestinal phenotypeHuman Pathology, 2018
- Whole-genome sequencing for an enhanced understanding of genetic variation among South AfricansNature Communications, 2017
- Next-generation sequencing in familial breast cancer patients from LebanonBMC Medical Genomics, 2017
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Risk and Prognosis of Cancer in Patients with Nephrotic SyndromeThe American Journal of Medicine, 2014
- Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomasNature Genetics, 2013
- The Role of Complement in Tumor Growth2013
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 2013
- The association between UGT1A7 polymorphism and cancer risk: A meta-analysisCancer Epidemiology, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012